Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSPO | P30536 | 4/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
| ▸ | RAC2 | P15153 | 1/20 | 0.31 |
| ▸ | RAC3 | P60763 | 1/20 | 0.31 |
| ▸ | CDC42 | P60953 | 1/20 | 0.31 |
| ▸ | RAC1 | P63000 | 1/20 | 0.31 |
| ▸ | EDNRB | P24530 | 1/20 | 0.30 |
| ▸ | EDNRA | P25101 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26340237 | 0.97 | TSPO (0.35) | TSPOKDM4EATML3MBTL1RAC2 | |
| SCHEMBL26340239 | 0.96 | TSPO (0.36) | TSPOKDM4EATML3MBTL1RAC2 | |
| SCHEMBL26340235 | 0.95 | TSPO (0.34) | TSPOKDM4EATML3MBTL1 | |
| SCHEMBL26371706 | 0.95 | TSPO (0.34) | TSPOKDM4EATML3MBTL1 | |
| SCHEMBL14521294 | 0.95 | KDM4E (0.36) | TSPOKDM4EATML3MBTL1RAC2 | |
| SCHEMBL26337781 | 0.94 | TSPO (0.33) | TSPOKDM4EATML3MBTL1 | |
| SCHEMBL26336149 | 0.94 | KDM4E (0.33) | TSPOKDM4EATML3MBTL1RAC2 | |
| SCHEMBL14362589 | 0.94 | KDM4E (0.36) | TSPOKDM4EATML3MBTL1RAC2 | |
| SCHEMBL10160969 | 0.93 | KDM4E (0.38) | TSPOKDM4EATML3MBTL1NPY5R | |
| SCHEMBL26336148 | 0.93 | KDM4E (0.34) | KDM4EATML3MBTL1RAC2RAC3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8288012-B2 | Anthracene derivatives and light-emitting devices using the anthracene derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-8288012-B2 | Anthracene derivatives and light-emitting devices using the anthracene derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-16 | — | — | US | disclosed |
| US-20120211728-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-08-23 | — | — | US | disclosed |
| US-20120211728-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2012-08-23 | — | — | US | disclosed |
| EP-2031036-B1 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LAB (JP) | 2012-06-27 | — | — | EP | disclosed |
| EP-2444470-A1 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-04-25 | — | — | EP | disclosed |
| US-8101289-B2 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-8101289-B2 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-01-24 | — | — | US | disclosed |
| US-20090058278-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-05 | — | — | US | disclosed |
| US-20090058278-A1 | Light-Emitting Element, Light-Emitting Device, and Electronic Appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-03-05 | — | — | US | disclosed |
| EP-2031036-A1 | Light-emitting element, light-emitting device, and electronic appliance | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2009-03-04 | — | — | EP | disclosed |
| US-20090004506-A1 | Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-01-01 | — | — | US | disclosed |
| US-20090004506-A1 | Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2009-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090004506-A1 | Anthracene Derivatives and Light-Emitting Devices Using the Anthracene Derivatives | CRY1, CYP1A1, GLB1 | TSPO 2918/4885KDM4E 3561/4885ATM 1030/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.